activins has been researched along with HIV Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, R; Burton, DR; Carnathan, DG; Crotty, S; Dhadvai, P; Ellebedy, AH; Enemuo, CA; Gebru, EH; Kaushik, K; Locci, M; Ozorowski, G; Pauthner, MG; Rasheed, MAU; Silvestri, G; Ward, AB | 1 |
| Adland, E; Goulder, PJR; Groll, A; Kløverpris, H; Leslie, A; Moore, PL; Morris, L; Muenchhoff, M; Ndung'u, T; Ogongo, P; Porterfield, JZ; Roider, J | 1 |
2 other study(ies) available for activins and HIV Infections
| Article | Year |
|---|---|
Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers.
Topics: Activins; Adjuvants, Immunologic; AIDS Vaccines; Animals; Antibody Formation; Disease Models, Animal; env Gene Products, Human Immunodeficiency Virus; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunization; Immunization Schedule; Immunophenotyping; Macaca mulatta; Male; Protein Multimerization; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 2020 |
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children.
Topics: Activins; Adolescent; Biomarkers; Broadly Neutralizing Antibodies; Chemokine CXCL13; Child; Cohort Studies; Disease Progression; Germinal Center; HIV Antibodies; HIV Infections; HIV-1; Humans; Interleukin-5; Neutralization Tests; T-Lymphocytes, Helper-Inducer; Viral Load | 2019 |